I did a 10K row yesterday. Finished JUST under 43 minutes. 🥵 💪

#FitnessSky #GymSky #HealthSky #WorkoutSky #CardioSky

Researchers: New MRI System Could Aid Early Detection of Heart Health March 26, 2026 —The heart’s ability to use oxygen efficiently is a critical indicator of its health, but tests to measure this function have drawbacks that can limit their use. A new Cedars-Sinai Health Sciences University study found that a new MRI system developed at Cedars-Sinai might overcome this challenge. The findings, published in Science Translational Medicine, could one day improve management of heart failure, in which the heart fails to pump enough blood to meet the body’s need for blood and oxygen. Poor use of oxygen by the heart is an early indicator of heart failure, which...

🧠 Researchers are developing a new MRI system that may help detect early signs of heart disease before symptoms appear, offering the potential for earlier intervention and improved patient outcomes ➡️ https://ow.ly/S2WR50YBXxT

#CardioSky

For reference, here's our work on CMR phenotyping:

pubmed.ncbi.nlm.nih.gov/40400457/
pubmed.ncbi.nlm.nih.gov/36103165/
pubmed.ncbi.nlm.nih.gov/31954639/
pubmed.ncbi.nlm.nih.gov/31070111/

#WhyCMR #sarcoidosis #cardiacsarcoidosis #CardioSky

This study confirms, for the first time in a fully prospective cohort, the prognostic importance of CMR phenotyping in cardiac sarcoidosis. The high-risk CMR phenotype had 100% NPV, indicating the absence of VA events among patients without the high-risk phenotype. LGE phenotyping showed much higher interobserver reproducibility than LGE quantification and was five-fold faster.

In science, successful replication is the ultimate quality check!

This is a highlight for our research group—David Birnie's group (one of the biggest names in cardiac sarcoidosis) just independently replicated our CMR phenotyping work!

doi.org/10.1093/ehji...
#EHJIMP #CardioSky #sarcoidosis

Mentorship pairing #1: Al and equity in ATTR-CM Sponsored by Alnylam Pharmaceuticals Mentorship pairing #2: Women and ATTR-CM detection Sponsored by BridgeBio Mentorship pairing #3: Adherence to lipid-lowering therapy in women Sponsored by Daiichi Sankyo Europe Application deadline April 10

The 2026 Mentorship Awards connect women physicians in mentorship to advance research & leadership in cardiology.

Focus areas: AI & equitable ATTR-CM care, early diagnosis & disparities, long-term lipid therapy.

Apply by April 10: womenasone.org/for-p...

#WomenAsOneAwards #CardioSky

Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology

"Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology."
Publié en mars dans J Am Coll Cardiol.
#MedSky #CardioSky @accintouch.bsky.social
www.jacc.org/doi/10.1016/...

'Happy Easter from the British Society of Echocardiography' on a blue and green striped background

Happy Easter from the British Society of Echocardiography

#echosky #cardiosky

Great to contribute to @globalhearthub.bsky.social Empower Series webinar a brilliant resource helping people understand heart health and navigate care with confidence
Professionals can learn so much from lived experience
Explore the series:
youtube.com/@globalheart...
#cardiosky #womenshearthealth

@uoflenvirome.bsky.social @uoflmedicine.bsky.social @stevenpjones.bsky.social #musclesky #cardiosky #HFrEF #heartfailure #skeletalmuscle #cardiology

The #EMPOWERCAD study tackles women’s underrepresentation in PCI trials.

An IVL-first approach in women with calcified CAD showed high procedural success, improved 30-day quality of life, and strong safety.

Advancing women in cardiology advances care.

www.jscai.org/articl...

#CardioSky

Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On The final results of RECOVERY add support to addressing severe aortic stenosis right away rather than waiting for symptoms.

🫀 New long-term data highlight benefits of early intervention in asymptomatic severe aortic stenosis. At 10+ years, early #SAVR was linked to lower CV and all-cause mortality vs. watchful waiting ➡️ www.tctmd.com/news/benefits-early-savr...

#CardioSky

Our 10th Anniversary - and we keep getting better every year. Join us in Denver, CO August 6-8, 2026 for interactive case-based learning with world-renowned operators. Check out the agenda at cvinnovations.org/cvi2026/ #cme #conference #cardiology #medsky #cardiosky

Last weekend at #ACC26 was 😍

✨Celebrating & growing our community
✨Packed panel with Pfizer
✨Dr Roxana Mehran becoming @accintouch.bsky.social President
✨2025 Mentorship Award winner Dr. Preet Shaikh presenting research developed through the Awards

We're moving cardiology forward
#CardioSky

Left atrial appendage closure fails to match medical therapy in high-risk AF Left atrial appendage closure fails to match medical therapy for preventing stroke and major events in high-risk atrial fibrillation, the CLOSURE-AF trial shows.

From #ACC2026 - Left atrial appendage closure fails to match medical therapy for preventing #stroke and major events in high-risk atrial fibrillation, the CLOSURE-AF trial shows.

👉 buff.ly/wXa91qR

#CardioSky #MedNews

Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial There was no significant difference in all-cause mortality at 10 years between PCI and CABG for patients with unprotected left main coronary artery disease and no additional complex lesions, indicatin...

“Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.”
Publié ce jour dans @thelancet.com.
#MedSky #CardioSky
www.thelancet.com/journals/lan...

Oral Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications Injectable GLP-1 medicines have been shown to improve cardiovascular and renal outcomes in patients with type 2 diabetes, but do the oral agents demonstrate the same benefits?

Injectable #GLP1 medicines have been shown to improve cardiovascular and renal outcomes in patients with #Type2Diabetes, but do the oral agents demonstrate the same benefits?

👉 buff.ly/Rj4TWst

#CardioSky

A picture of Irish countryside with event banners overlaid

🚨BOOK NOW

💚 Irish regional webinar: Case-based discussions
📅 Tuesday 19 May 2026
🖥️ Webinar
📜 2 BSE points

Programme coming soon - secure your place: bsecho.org/iCore/Events/Event_displ...

#echosky #cardiosky

New multicenter study following nearly 2,000 patients for 10 years after TAVR with self-expanding valves reinforces why sex-specific analysis is essential and highlights a critical nuance: women experienced more stroke and transient ischemic attacks.

Women make up ~50% of real-world TAVR patients but remain underrepresented in trials. A 10-year study (~2,000 pts, 54.9% women) shows better survival in women, similar valve durability, but higher stroke risk.

Sex-specific care matters.

Read more: link.springer.com/ar...

#CardioSky

🩻 One way to protect yourself in the #CathLab from radiation is by correctly wearing your gear. Share a picture of yourself wearing your lead and SCAI hat and let us know your best radiation safety tips! ☢️

#SCAIHatDay #PhysicianWellbeing #SCAIWellness #CardioSky

Adding evolocumab to statins reduces MACE even without overt atherosclerosis Adding evolocumab to background statin therapy substantially reduces the risk for a major adverse cardiovascular event in high-risk patients with diabetes who do not have significant atherosclerosis.

From #ACC2026 - Adding evolocumab to background statin therapy substantially reduces the risk for MACE in high-risk patients with #diabetes who do not have significant atherosclerosis.

👉 buff.ly/T8IcYzB

#CardioSky #MedNews

Considering applying to the level 3 pilot project? Our President, Dan Augustine, outlines why cardiologist support is so important for those applying

Click here for further details: www.bsecho.org/Public/News/Articles/202...

#echosky #cardiosky

#Cardioobstetrics 📢
🫀April =CPP Congress month!
🤰🏽👀you there!

#Cardiosky #medsky #obgynsky #reprosky #mfmsky

The effect of adding visual summaries to data visualizations on patient judgments of hypertension control AbstractObjectives. To test the impact of visual summaries of blood pressure (BP) data (eg, stoplight and gradient displays), within the context of a patie

"...simplified verbal summaries alone are effective in helping #patients extract important gist information (i.e., “I am above my goal”) from noisy personal health data." academic.oup.com/jamiaopen/ar...

#MedSky #CardioSky #PatientExperience #HealthLiteracy #PublicHealth #HealthCommunication

Almost time! 💥 Sponsorship & satellite opportunities open April 8 at 1:00 PM EDT for #TCT2026 🌴 Spots go fast — be ready!

Sponsorships 👉 https://ow.ly/eRv850YCCpT
Satellites 👉 https://ow.ly/ETb950YCCpS

#CardioSky #MedSky

#cardiosky #echosky #emimcc

Protected PCI and Cardiogenic Shock Interventional Octagon Submissions Open - Cardiovascular Innovations Please join us at the CVI’s Interventional Octagon competitive case-based learning webinar on 4/14/26 at 9 pm ET. This CME session will focus on Protected PCI and Cardiogenic Shock.  Fellows...

Submit cases for the Interventional Octagon by 4/5. Topic: Protected PCI and Cardiogenic Shock. Finalists earn travel grants to CVI in Denver 8/6-8/8. Complimentary webinar 4/14 at 9 pm ET. Submissions/webinar registration at: cvinnovations.org/2026/03/05/c... #MedSky #CardioSky

From LAAC vs. NOACs to hybrid AI adjudication, DCRI faculty shaped the science at #ACC26. Catch up on the sessions you may have missed: dcri.org/acc26 #CardioSky #HeartDisease

🔍Looking to deepen your expertise in #tricuspid #TEER interventions? The comprehensive #SCAITTEEREbook covers every step of the procedure, from patient selection to complication management.

Download the ebook for free➡️ https://ow.ly/Oh4F50YyRLv

#InterventionalCardiology #CardioSky

Quality Improvement for Institutions

Great funding opportunity from @accintouch.bsky.social to conduct QI activities! cvquality.acc.org/accreditatio... #cardiosky

Dr. Amar Krishnaswamy can’t wait for #NYValves2026 — and neither can we! 🎉

Get ready to walk away with fresh insights for patient care and long-term planning that’ll help you deliver better outcomes. 💪

Secure your spot today! https://ow.ly/Xhiw50YxJSt

#CardioSky #MedSky